London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Karen Sherwood
)
- Job title
- Institution
- The University of British Columbia & Vancouver General Hospital, Canada
- Biography
Dr Karen Sherwood graduated from the University of Edinburgh and completed post-doctoral training in genetics, computational biology and immunology at the Roslin Institute in Scotland and the Heart Lung Institute in Vancouver. She is Director of the British Columbian Provincial Transplant Immunology Department at Vancouver General Hospital, Co-Principal Investigator and scientific Lead for the Genome Canada Transplant Consortium program, and Cluster Director for University of British Columbia Precision Transplant Cluster.
- Recent publications
Tran, J.N. et al. Novel alleles in the era of next-generation sequencing-based HLA typing calls for standardization and policy. Front Genet. 14:1282834 (2023).
DOI: 10.3389/fgene.2023.1282834Kakodkar, P. et al. Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation. Front Genet. 14:1282947 (2023).
DOI: 10.3389/fgene.2023.1282947Fenninger, F. et al. Comprehensive immune profiling of SARS-CoV-2 infected kidney transplant patients. Front Transplant. 2:1261023 (2023).
DOI: 10.3389/frtra.2023.1261023Sherwood, K.R. et al. Genome Canada precision medicine strategy for structured national implementation of epitope matching in renal transplantation. Hum Immunol. 83(3):264-269 (2022).
DOI: 10.1016/j.humimm.2022.01.002
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.